Hematology/Oncology
Baclig NV, McCann KE. Updates in the treatment of HR+HER2- breast cancer. Curr Opin Obstet Gynecol. 2024 Feb 1;36(1):57-63. doi: 10.1097/GCO.0000000000000925. Epub 2023 Dec 7.[...]
Britten K, McAndrew N. New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Curr Opin[...]
Shehata MS, Lofftus SY, Park JY, Singh AS, Federman NC, Eilber FC, Crompton JG, McCaw TR. Sarcoma in patients with Lynch syndrome and response to[...]
Nikitas J, Ong WL, Carrier N, Romero T, Millar J, Steinberg ML, Rettig MB, Boutros PC, Reiter R, Nickols NG, Valle L, McGuire SE, Spratt[...]
2023 has given us much to celebrate in the department of medicine. I would like to take this opportunity to thank YOU for all that you do[...]
Crespi CM, Ganz PA, Partridge AH, Wolff A, Joffe H, Irwin MR, Thure K, Petersen L, Tina Shih YC, Bower JE. Work Productivity Among Younger[...]
Brauer ER, Petersen L, Ganz PA. Survivorship Care in Breast Cancer: Understanding Implementation Barriers through the Lens of the Theoretical Domains Framework. JNCI Cancer Spectr.[...]
Wang R, Mi Y, Ni J, Wang Y, Ding L, Ran X, Sun Q, Tan SY, Koeffler HP, Feng N, Chen YQ. Identification of PRDX5[...]
Kumar SK, Callander NS, Adekola K, Anderson LD, Baljevic M, Baz R, Campagnaro E, Castillo JJ, Costello C, D'Angelo C, Devarakonda S, Elsedawy N, Garfall[...]
Giafaglione JM, Crowell PD, Delcourt AML, Hashimoto T, Ha SM, Atmakuri A, Nunley NM, Dang RMA, Tian M, Diaz JA, Tika E, Payne MC, Burkhart[...]